AMICUS THERAPEUTICS, INC. — Director's Dealing 2017

Jun 15, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2017-06-13

Reporting Person: ESSNER ROBERT (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-13	Common Stock	A	5814	$0.00	Acquired	5814	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-13	Stock Options (right to buy)	$8.60	A	16236	Acquired	2027-06-13	Common Stock (16236)	Direct

Footnotes

F1: One hundred percent of the shares subject to this option will vest and become exercisable on the date of the annual meeting of the stockholders of the issuer to be held in 2018.